CRISPR: three new developments in the world of gene editing
In this article, we outline three recent studies that have advanced the potential uses of CRISPR in the biomedical field.
List view / Grid view
In this article, we outline three recent studies that have advanced the potential uses of CRISPR in the biomedical field.
Researchers have identified an enzyme required for the formation of sperm and chromosomal pairing, which they say could be a target to treat male infertility.
An mRNA vaccine has been developed which has elicited strong immune responses in mice in the presence of maternal antibodies.
New research goes against the paradigm of HIV control that focuses on killing off infected cells and supports a model in which viral suppression could possibly serve as a cure.
Drug Target Review lists its 10 most popular news stories from 2019, summarising the drug targets that you wanted to read about.
An animal model to test HIV infection in infants could lead to biomarkers that predict viral rebound after ART interruption.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.
A study has reported that genes delivered to rhesus monkeys are still being expressed four years later.
Researchers have used wasp venom to create variants of a peptide that is potent against bacteria but nontoxic to human cells...
Anti-malaria drugs, called chloroquines, target PPT1 from cancer cells, with researchers identifying how the drugs eliminate tumour growth in cancers...
Investigational therapeutic candidate made with four antibodies tethered together shows promise against influenza A and B...
RNA analysis of 20,000 cardiac cells from heart tissue in both ordinary and deceased mice showed an insight to the development of heart disease...
Researchers have found another common thread linking nearly all of the TNR expansion diseases...
Researchers have developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors...
Antibody mAb806 may be useful in treating aggressive forms of glioblastoma multiform...